Literature DB >> 32505496

Gastrointestinal malignancy in cystic fibrosis.

Natasha Emily Hough1, Stephen James Chapman2, William George Flight2.   

Abstract

Cystic fibrosis (CF) is a multisystem disease affecting the gastrointestinal (GI) tract as well as the lungs. As survival has increased significantly over the past few decades, complications not seen previously have become apparent. There is an overall increased rate of malignancy in CF, particularly from the GI tract and in the post-transplant population. The most common sites of malignancy are the pancreatico-biliary and digestive tract, as well as an increased rate of testicular cancer. Using an illustrative case of metastatic oesophageal malignancy which initially appeared to be hepatic in origin, we have reviewed the literature surrounding malignancy in CF with a particular focus on the GI tract. Crown
Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer screening; Colon cancer; Cystic fibrosis; Metastases; Oesophageal cancer

Mesh:

Substances:

Year:  2020        PMID: 32505496     DOI: 10.1016/j.prrv.2020.03.002

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  2 in total

1.  Novel CFTR Modulators for Treating Cystic Fibrosis.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-18       Impact factor: 4.632

2.  Malignancies in patients with cystic fibrosis: a case series.

Authors:  Dorothea Appelt; Teresa Fuchs; Gratiana Steinkamp; Helmut Ellemunter
Journal:  J Med Case Rep       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.